Evaluation of the Long- Term Effects of Spiriva on Lung Function in COPD Patients [clinicaltrials:NCT00144339]

Bio2RDF uri

Evaluation of the Long- Term Effects of Spiriva on Lung Function in COPD Patients [clinicaltrials:NCT00144339]

Clinical Study [clinicaltrials_vocabulary:Clinical-Study]

clinicaltrials resource [clinicaltrials_vocabulary:Resource]

http://bio2rdf.org/clinicaltrials:NCT00144339

Bio2RDF identifier

NCT00144339

http://www.w3.org/2001/XMLSchema#string

Bio2RDF namespace

clinicaltrials

http://www.w3.org/2001/XMLSchema#string

Bio2RDF uri

http://bio2rdf.org/clinicaltrials:NCT00144339

http://www.w3.org/2001/XMLSchema#string

identifiers.org URI

NCT00144339

actual enrollment [clinicaltrials_vocabulary:actual-enrollment]

5,993

http://www.w3.org/2001/XMLSchema#integer

authority [clinicaltrials_vocabulary:authority]

clinicaltrials_resource:6fea6ff7e9d0f9f9ecda508a7c7c5ab1

baseline [clinicaltrials_vocabulary:baseline]

baseline for NCT00144339 [clinicaltrials_resource:NCT00144339/baseline]

brief summary [clinicaltrials_vocabulary:brief-summary]

The primary objective o ...... r time in patients with COPD.

http://www.w3.org/2001/XMLSchema#string

brief title [clinicaltrials_vocabulary:brief-title]

Evaluation of the Long- Term Effects of Spiriva on Lung Function in COPD Patients

http://www.w3.org/2001/XMLSchema#string

clinical result [clinicaltrials_vocabulary:clinical-result]

clinical results for clinicaltrials:NCT00144339 [clinicaltrials_resource:7f4210d3be3aaf6dd8ce3dd59a81caa5]

clinicaltrials_vocabulary:other outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:other-outcome]

Pre-bronchodilator Forced Expiratory Volume in One Second (FEV1) Rate of Decline From Day 30 to 4 Years From day 30 to 4 years [clinicaltrials_resource:05458222667eed271e7c03afcd271240]

Pre-bronchodilator Forced Expiratory Volume in One Second (FEV1) Rate of Decline From Day 30 to 4 Years From day 30 to 4 years [clinicaltrials_resource:06e88121cfb2712d05f61a5534ed3301]

Pre-bronchodilator Forced Expiratory Volume in One Second (FEV1) Rate of Decline From Day 30 to 4 Years From day 30 to 4 years [clinicaltrials_resource:15ddea4692b5e8bf03d5f59cd004ac2a]

Pre-bronchodilator Forced Expiratory Volume in One Second (FEV1) Rate of Decline From Day 30 to 4 Years From day 30 to 4 years [clinicaltrials_resource:1d657b6eabcb6074e3ce2cf2f467d4c7]

Pre-bronchodilator Forced Expiratory Volume in One Second (FEV1) Rate of Decline From Day 30 to 4 Years From day 30 to 4 years [clinicaltrials_resource:2880681a79933bde09eb3b5fc4754dc9]

Pre-bronchodilator Forced Expiratory Volume in One Second (FEV1) Rate of Decline From Day 30 to 4 Years From day 30 to 4 years [clinicaltrials_resource:2fc14e0596e4bbc327d7ab7eb39963a9]

Pre-bronchodilator Forced Expiratory Volume in One Second (FEV1) Rate of Decline From Day 30 to 4 Years From day 30 to 4 years [clinicaltrials_resource:471efb1f49fe26d316eb5b9131e7d4a0]

Pre-bronchodilator Forced Expiratory Volume in One Second (FEV1) Rate of Decline From Day 30 to 4 Years From day 30 to 4 years [clinicaltrials_resource:6748617f7a3b85377d974bd29c7a3510]

Pre-bronchodilator Forced Expiratory Volume in One Second (FEV1) Rate of Decline From Day 30 to 4 Years From day 30 to 4 years [clinicaltrials_resource:80171eb6c6ceb53330c36fafef47bdd2]

Pre-bronchodilator Forced Expiratory Volume in One Second (FEV1) Rate of Decline From Day 30 to 4 Years From day 30 to 4 years [clinicaltrials_resource:8829e3057122d8ddb89375de1f42c331]

clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]

Pre-bronchodilator Forced Expiratory Volume in One Second (FEV1) Rate of Decline From Day 30 to 4 Years From day 30 to 4 years [clinicaltrials_resource:1166683f7b8b266fbee1d82a625108dd]

Pre-bronchodilator Forced Expiratory Volume in One Second (FEV1) Rate of Decline From Day 30 to 4 Years From day 30 to 4 years [clinicaltrials_resource:4c0b2f2dc8cffd38fcb46f5df5fbf59b]

clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]

Pre-bronchodilator Forced Expiratory Volume in One Second (FEV1) Rate of Decline From Day 30 to 4 Years From day 30 to 4 years [clinicaltrials_resource:07cb1ebfd188712b92d7842916a308b5]

Pre-bronchodilator Forced Expiratory Volume in One Second (FEV1) Rate of Decline From Day 30 to 4 Years From day 30 to 4 years [clinicaltrials_resource:092c11a05e71ca4302bfaa2505738d2c]

Pre-bronchodilator Forced Expiratory Volume in One Second (FEV1) Rate of Decline From Day 30 to 4 Years From day 30 to 4 years [clinicaltrials_resource:0d1ec3b56db796878adbabb78b8d0622]

Pre-bronchodilator Forced Expiratory Volume in One Second (FEV1) Rate of Decline From Day 30 to 4 Years From day 30 to 4 years [clinicaltrials_resource:0ff78ae027595754ccb4b617c34a07a6]

Pre-bronchodilator Forced Expiratory Volume in One Second (FEV1) Rate of Decline From Day 30 to 4 Years From day 30 to 4 years [clinicaltrials_resource:144b2d7624d780f6b58c3e16dc1c4b19]

Pre-bronchodilator Forced Expiratory Volume in One Second (FEV1) Rate of Decline From Day 30 to 4 Years From day 30 to 4 years [clinicaltrials_resource:14583ccd63f89f8f8d11be3293c6840a]

Pre-bronchodilator Forced Expiratory Volume in One Second (FEV1) Rate of Decline From Day 30 to 4 Years From day 30 to 4 years [clinicaltrials_resource:196503604d0ed0343d4305a5dff1b976]

Pre-bronchodilator Forced Expiratory Volume in One Second (FEV1) Rate of Decline From Day 30 to 4 Years From day 30 to 4 years [clinicaltrials_resource:199928c569dfacebc7e12f8683d25866]

Pre-bronchodilator Forced Expiratory Volume in One Second (FEV1) Rate of Decline From Day 30 to 4 Years From day 30 to 4 years [clinicaltrials_resource:1e201c97f6b8298085c64d08cac68002]

Pre-bronchodilator Forced Expiratory Volume in One Second (FEV1) Rate of Decline From Day 30 to 4 Years From day 30 to 4 years [clinicaltrials_resource:2552d7d11762fac81cc202d1300f5a6f]

download date [clinicaltrials_vocabulary:download-date]

ClinicalTrials.gov processed this data on August 10, 2015

http://www.w3.org/2001/XMLSchema#string

eligibility [clinicaltrials_vocabulary:eligibility]

eligibility for clinicaltrials:NCT00144339 [clinicaltrials_resource:6ff6ce10ed9343b8546afb5418e05a36]

firstreceived date [clinicaltrials_vocabulary:firstreceived-date]

2005-09-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

firstreceived results date [clinicaltrials_vocabulary:firstreceived-results-date]

2009-02-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

has expanded access [clinicaltrials_vocabulary:has-expanded-access]

http://www.w3.org/2001/XMLSchema#string

intervention [clinicaltrials_vocabulary:intervention]

placebo [clinicaltrials_resource:771772a364439361998298c491c1a544]

tiotropium [clinicaltrials_resource:d85f9017f863ff88c5a09df6f01721a2]

intervention browse [clinicaltrials_vocabulary:intervention-browse]

Tiotropium [clinicaltrials_resource:17b37513b438cefbf8247a55601652f1]

lastchanged date [clinicaltrials_vocabulary:lastchanged-date]

2014-05-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

lead sponsor [clinicaltrials_vocabulary:lead-sponsor]

Boehringer Ingelheim [clinicaltrials_resource:5d012cfae6e8b67d8437e7145ea9a68f]

link [clinicaltrials_vocabulary:link]

[clinicaltrials_resource:9a0922663082a925ec9a6506d38132f7]

[clinicaltrials_resource:c7ef8d2884fbebf2142aab6ac0e34c59]

location [clinicaltrials_vocabulary:location]

205.235.3779 Boehringer Ingelheim Investigational Site [clinicaltrials_resource:c33e3f9dc880a10dc79cd24a3c258199]

nct id [clinicaltrials_vocabulary:nct-id]

NCT00144339

http://www.w3.org/2001/XMLSchema#string

official title [clinicaltrials_vocabulary:official-title]

A Randomized, Double-blind, Pl ...... tive Pulmonary Disease (COPD).

http://www.w3.org/2001/XMLSchema#string

org study id [clinicaltrials_vocabulary:org-study-id]

2.0523500061035156e+2

http://www.w3.org/2001/XMLSchema#float

outcome [clinicaltrials_vocabulary:outcome]

Pre-bronchodilator Forced Expiratory Volume in One Second (FEV1) Rate of Decline From Day 30 to 4 Years [clinicaltrials_resource:NCT00144339/outcome/1]

overall official [clinicaltrials_vocabulary:overall-official]

Boehringer Ingelheim [clinicaltrials_resource:1f5af28df428803ccefd08f103ea82a2]

overall status [clinicaltrials_vocabulary:overall-status]

Completed [clinicaltrials_resource:07ca5050e697392c9ed47e6453f1453f]

oversight [clinicaltrials_vocabulary:oversight]

Czech Republic: State Institute for Drug Control (SUKL), CZ-100 41 Prague 10 [clinicaltrials_resource:78444c8e2b5788db0f6da181b21c677a]

participant flow [clinicaltrials_vocabulary:participant-flow]

participant flow for clinicaltrials:NCT00144339 [clinicaltrials_resource:42d2efbce652ce82f0edbbe433645612]

phase [clinicaltrials_vocabulary:phase]

Phase 3 [clinicaltrials_resource:8357418e2694434468870b487644532d]

primary completion date [clinicaltrials_vocabulary:primary-completion-date]

2008-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

reported events [clinicaltrials_vocabulary:reported-events]

Reported events for NCT00144339 [clinicaltrials_resource:d55a3e449d8236a2c3e9524aa1e6fea0]

responsible party [clinicaltrials_vocabulary:responsible-party]

Boehringer Ingelheim, Study Chair, Boehringer Ingelheim [clinicaltrials_resource:647bb26ee689091d3c2c5b3dc0e985bd]

source [clinicaltrials_vocabulary:source]

Boehringer Ingelheim [clinicaltrials_resource:5d012cfae6e8b67d8437e7145ea9a68f]

start date [clinicaltrials_vocabulary:start-date]

2002-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

study design [clinicaltrials_vocabulary:study-design]

clinicaltrials:NCT00144339 study design [clinicaltrials_resource:50b8bfe088faa15372b75d10fb4f21cb]

study type [clinicaltrials_vocabulary:study-type]

Interventional [clinicaltrials_resource:843ac00ae5d0b7c7defb84fb42c2ce31]

url [clinicaltrials_vocabulary:url]

NCT00144339

verification date [clinicaltrials_vocabulary:verification-date]

2014-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

identifier

clinicaltrials:NCT00144339

http://www.w3.org/2001/XMLSchema#string

title

Evaluation of the Long- Term Effects of Spiriva on Lung Function in COPD Patients

@en

inDataset

clinicaltrials_resource:bio2rdf.dataset.clinicaltrials.R3

type

Clinical Study [clinicaltrials_vocabulary:Clinical-Study]

clinicaltrials resource [clinicaltrials_vocabulary:Resource]